BVF INC/IL - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 92 filers reported holding CTI BIOPHARMA CORP in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.

Quarter-by-quarter ownership
BVF INC/IL ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$37,014,688
-30.1%
8,813,0210.0%1.35%
-39.5%
Q4 2022$52,966,256
+3.3%
8,813,0210.0%2.24%
+5.5%
Q3 2022$51,292,000
-3.8%
8,813,021
-1.3%
2.12%
-17.7%
Q2 2022$53,310,000
+27.8%
8,929,6900.0%2.58%
+54.4%
Q1 2022$41,702,000
+88.3%
8,929,6900.0%1.67%
+107.5%
Q4 2021$22,146,000
-15.9%
8,929,6900.0%0.80%
-21.8%
Q3 2021$26,343,000
+18.0%
8,929,6900.0%1.03%
+22.8%
Q2 2021$22,324,000
+10.7%
8,929,690
+28.9%
0.84%
+10.7%
Q1 2021$20,165,000
-9.6%
6,929,6900.0%0.76%
-13.9%
Q4 2020$22,314,000
+49.8%
6,929,6900.0%0.88%
+8.3%
Q3 2020$14,899,000
+85.4%
6,929,6900.0%0.81%
+63.5%
Q2 2020$8,038,000
+26.1%
6,929,6900.0%0.50%
-16.5%
Q1 2020$6,375,000
-41.8%
6,929,6900.0%0.59%
-28.4%
Q4 2019$10,949,000
+89.9%
6,929,6900.0%0.83%
+37.0%
Q3 2019$5,766,000
-3.2%
6,929,6900.0%0.61%
-6.8%
Q2 2019$5,955,000
-11.4%
6,929,6900.0%0.65%
-13.7%
Q1 2019$6,723,000
+32.2%
6,929,6900.0%0.75%
+13.4%
Q4 2018$5,084,000
-66.0%
6,929,6900.0%0.66%
-49.5%
Q3 2018$14,968,000
-56.6%
6,929,6900.0%1.32%
-61.0%
Q2 2018$34,510,000
+27.7%
6,929,6900.0%3.37%
+22.9%
Q1 2018$27,026,000
+17.3%
6,929,690
-19.4%
2.74%
-1.3%
Q4 2017$23,038,000
-16.0%
8,596,3570.0%2.78%
-20.3%
Q3 2017$27,422,000
-3.6%
8,596,3570.0%3.49%
-21.1%
Q2 2017$28,454,000
+51.2%
8,596,357
+91.9%
4.42%
+38.1%
Q1 2017$18,815,0004,479,6913.20%
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q1 2022.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders